SG Americas Securities’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,753
Closed -$147K 2535
2025
Q1
$147K Buy
9,753
+3,557
+57% +$53.6K ﹤0.01% 2455
2024
Q4
$102K Sell
6,196
-3,289
-35% -$54.1K ﹤0.01% 2432
2024
Q3
$234K Buy
9,485
+2,858
+43% +$70.5K ﹤0.01% 2096
2024
Q2
$168K Sell
6,627
-1,988
-23% -$50.4K ﹤0.01% 1997
2024
Q1
$219K Buy
8,615
+627
+8% +$15.9K ﹤0.01% 1695
2023
Q4
$181K Buy
7,988
+1,341
+20% +$30.4K ﹤0.01% 2049
2023
Q3
$124K Buy
+6,647
New +$124K ﹤0.01% 2400
2023
Q2
Sell
-7,358
Closed -$211K 1948
2023
Q1
$211K Buy
+7,358
New +$211K ﹤0.01% 2167
2022
Q1
Sell
-16,439
Closed -$589K 2568
2021
Q4
$589K Sell
16,439
-851
-5% -$30.5K ﹤0.01% 1861
2021
Q3
$736K Buy
+17,290
New +$736K ﹤0.01% 1995
2021
Q2
Sell
-16,334
Closed -$666K 2494
2021
Q1
$666K Buy
+16,334
New +$666K ﹤0.01% 1641
2020
Q4
Sell
-41,849
Closed -$1.48M 2783
2020
Q3
$1.48M Buy
41,849
+32,811
+363% +$1.16M 0.01% 777
2020
Q2
$341K Buy
9,038
+3,499
+63% +$132K ﹤0.01% 2081
2020
Q1
$160K Buy
5,539
+1,169
+27% +$33.8K ﹤0.01% 2251
2019
Q4
$227K Sell
4,370
-42,806
-91% -$2.22M ﹤0.01% 2062
2019
Q3
$2.59M Buy
47,176
+41,421
+720% +$2.27M 0.02% 693
2019
Q2
$234K Sell
5,755
-722
-11% -$29.4K ﹤0.01% 2017
2019
Q1
$196K Buy
6,477
+3,235
+100% +$97.9K ﹤0.01% 2262
2018
Q4
$109K Sell
3,242
-596
-16% -$20K ﹤0.01% 2286
2018
Q3
$162K Sell
3,838
-2,690
-41% -$114K ﹤0.01% 2317
2018
Q2
$209K Buy
+6,528
New +$209K ﹤0.01% 2250
2017
Q4
Sell
-2,041
Closed -$118K 2529
2017
Q3
$118K Buy
+2,041
New +$118K ﹤0.01% 2674
2017
Q1
Sell
-3,163
Closed -$155K 2779
2016
Q4
$155K Sell
3,163
-770
-20% -$37.7K ﹤0.01% 2250
2016
Q3
$188K Buy
+3,933
New +$188K ﹤0.01% 2254
2015
Q1
Sell
-4,044
Closed -$165K 2096
2014
Q4
$165K Buy
+4,044
New +$165K ﹤0.01% 2304